Capricor announced it intends to file a BLA for deramiocel for treatment of patients with DMD cardiomyopathy. Click here to ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Capricor Therapeutics (CAPR – Research Report). The ...

Rep. Frank Pallone (D-Long Branch)’s Cardiomyopathy Health, Education, Awareness, Research, and Training in Schools (HEARTS) ...

This is called, aptly, obstructive hypertrophic cardiomyopathy. This kind of obstruction is behind many of the more ...

Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a ...

Better imaging parameters may exist for risk stratification in nonischemic dilated cardiomyopathy (NIDCM), based on a ...

Discover BridgeBio Pharma's groundbreaking patent for treating ATTR cardiomyopathy with Compound 1, showcasing improved patient outcomes and reduced mortality rates.

With the recipient facing extreme breathing difficulty, a heart transplant was the only option left. While his family waited ...

Background Participation in regular exercise activities is recommended for patients with chronic heart failure. However, less ...

Diagnosis requires left ventricular regional wall motion abnormalities that extend beyond a single coronary artery distribution in the absence of obstructive coronary artery disease. Approximately ...

Take hypertrophic cardiomyopathy, or HCM, a primarily genetic condition that results in a thickening of the walls of the heart—specifically its left ventricle, which is the chamber that pumps ...

ARVC is a genetic condition of the heart muscle that can cause arrhythmias (abnormal heartbeats), heart failure, and sudden ...